---
title: "ADHD trait screening in adults with HIV and PrEP users in Switzerland: study protocol"
id: "medrxiv-10-screening-for-attention-deficit-hyperactivity-disorder-traits-among-adults"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-10-screening-for-attention-deficit-hyperactivity-disorder-traits-among-adults"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.08.26362490v1?rss=1"
published_at: "2026-09-08T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# ADHD trait screening in adults with HIV and PrEP users in Switzerland: study protocol
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-10-screening-for-attention-deficit-hyperactivity-disorder-traits-among-adults
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.08.26362490v1?rss=1)
- **Published At:** 2026-09-08T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This protocol describes a multicentre cross-sectional survey screening for **ADHD** traits among adults enrolled in the **Swiss HIV Cohort Study** (SHCS) and the SwissPrEPared cohort. - Participants attending routine visits over a 12-month recruitment period will complete the six-item **Adult ADHD Self-Report Scale Screener (ASRS-5)**. - A positive screen is defined as a weighted ASRS-5 score of 14 or higher; three additional items assess childhood traits, prior ADHD diagnosis, and interest in receiving the score or follow-up care. - Screening data will be linked to routinely collected cohort variables to describe sociodemographic, behavioural and clinical patterns. - Primary outcome: prevalence estimate of a positive ASRS-5 screen in each cohort with 95% Wilson score confidence intervals. - Secondary objectives: compare cohorts and examine associations of ADHD traits with substance use, sexual behaviour, STIs, depression and anxiety, treatment/prevention adherence, interest in long-acting HIV treatments, and gender identity/sexual orientation. - Target sample size is 800 participants per cohort to achieve an approximate 3% margin of error for prevalence estimates. - The study uses a Critical ADHD Studies framework and was co-created and co-led by people with lived experience. - Ethical oversight: the project is nested within SHCS and SwissPrEPared and operates under their existing ethical approvals and general participant consent. - Participants who screen positive and request follow-up will be offered consultation with an ADHD-experienced psychologist or psychiatrist. - Results will be shared publicly via the study website, peer-reviewed publication, and cohort communication channels; competing interests were declared as none by the authors.
## Clinical Analysis & Structured Key Points
Screening for attention-deficit/hyperactivity disorder traits among adults living with HIV or taking pre-exposure prophylaxis in Switzerland: a cross-sectional survey nested within the Swiss HIV Cohort Study and SwissPrEPared - a study protocol | medRxiv Skip to main content Screening for attention-deficit/hyperactivity disorder traits among adults living with HIV or taking pre-exposure prophylaxis in Switzerland: a cross-sectional survey nested within the Swiss HIV Cohort Study and SwissPrEPared - a study protocol David Jackson-Perry , Stephanie Campos Ochoa , Salvatore Corbisiero , Irene A Abela , Grace H Yoon , Matthias Cavassini , Benjamin Hampel , View ORCID Profile Alain Amstutz , the Swiss HIV Cohort Study , the SwissPrEPared Cohort Study doi: https://doi.org/10.64898/2026.09.08.26362490 David Jackson-Perry 1 Service of Infectious Diseases, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Stephanie Campos Ochoa 2 Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Basel, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Salvatore Corbisiero 3 ADHD Service Center and Center for Gender Identity Central Switzerland (ZGZ), Lucerne Psychiatry, Lucerne, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Irene A Abela 4 Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Grace H Yoon 5 Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Matthias Cavassini 1 Service of Infectious Diseases, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Benjamin Hampel 5 Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alain Amstutz 2 Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Basel, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Alain Amstutz For correspondence: alain.amstutz{at}unibas.ch Abstract Info/History Metrics Data/Code Preview PDF Abstract Introduction: People living with HIV experience disproportionately high rates of mental health conditions, yet adult attention-deficit/hyperactivity disorder (ADHD) is largely absent from the HIV literature. Traits associated with ADHD, together with social exclusion, adverse life events, stigma, and barriers to accessing healthcare may increase vulnerability to HIV acquisition and complicate adherence to treatment and prevention, and a comparable pathway may apply to users of HIV pre-exposure prophylaxis (PrEP). Prevalence data on ADHD in people living with HIV are limited to two small-scale studies, and no data exist for PrEP users. The objective of this study is to estimate the prevalence of ADHD traits among people living with HIV and PrEP users in Switzerland and to describe sociodemographic, behavioural and clinical patterns. The study was co-created and is co-led by people who, beyond their academic and clinical practices, have experiential knowledge of the topics being explored Methods and analysis: This is a multicentre cross-sectional survey using a Critical ADHD Studies framework and nested within the Swiss HIV Cohort Study (SHCS) and SwissPrEPared cohort. Over a 12-month recruitment period, participants attending routine visits at participating sites will complete the six-item Adult ADHD Self-Report Scale Screener (ASRS-5). A positive screen is defined as a weighted score of 14 or higher. Three additional items capture the presence of traits in childhood before the age of 12, any previously established ADHD diagnosis, and the participants wish to receive their score and/or a follow-up consultation with a psychologist or psychiatrist. Screening data will be linked to routinely collected cohort variables. The primary objective is to estimate the prevalence of a positive ASRS-5 screen, with 95% Wilson score confidence intervals, in each cohort. Secondary objectives include comparing cohorts and examining associations between ADHD traits and substance use, sexual behaviour, sexually transmitted infections, depression and anxiety, treatment and prevention adherence, use of and interest in long-acting HIV treatment modalities, and gender identity and sexual orientation. A target sample of 800 participants per cohort was calculated for a 3% prevalence margin of error. Ethics and dissemination: The study is nested within the SHCS and SwissPrEPared and falls under their existing ethical approvals and general participant consent. Participants who screen positive and wish to be followed up will be offered a consultation with an ADHD-experienced psychologist or psychiatrist. Results will be publicly available on the study website, published in peer-reviewed journals, and shared with participants and communities through lay summaries and cohort communication channels. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study is a nested project within the SHCS and SwissPrEPared and falls under their existing ethical approvals. All participants provided general data collection consent on joining the cohorts. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present work are contained in the manuscript Funder Information Declared Swiss HIV Cohort Study, https://ror.org/048hyya13 , #961 Swiss National Science Foundation, https://ror.org/00yjd3n13 , #P5R5-3_239044 Gilead Sciences Switzerland Sàrl Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted September 08, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Screening for attention-deficit/hyperactivity disorder traits among adults living with HIV or taking pre-exposure prophylaxis in Switzerland: a cross-sectional survey nested within the Swiss HIV Cohort Study and SwissPrEPared - a study protocol Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Screening for attention-deficit/hyperactivity disorder traits among adults living with HIV or taking pre-exposure prophylaxis in Switzerland: a cross-sectional survey nested within the Swiss HIV Cohort Study and SwissPrEPared - a study protocol David Jackson-Perry , Stephanie Campos Ochoa , Salvatore Corbisiero , Irene A Abela , Grace H Yoon , Matthias Cavassini , Benjamin Hampel , Alain Amstutz , the Swiss HIV Cohort Study , the SwissPrEPared Cohort Study medRxiv 2026.09.08.26362490; doi: https://doi.org/10.64898/2026.09.08.26362490 Share This Article: Copy Citation Tools Screening for attention-deficit/hyperactivity disorder traits among adults living with HIV or taking pre-exposure prophylaxis in Switzerland: a cross-sectional survey nested within the Swiss HIV Cohort Study and SwissPrEPared - a study protocol David Jackson-Perry , Stephanie Campos Ochoa , Salvatore Corbisiero , Irene A Abela , Grace H Yoon , Matthias Cavassini , Benjamin Hampel , Alain Amstutz , the Swiss HIV Cohort Study , the SwissPrEPared Cohort Study medRxiv 2026.09.08.26362490; doi: https://doi.org/10.64898/2026.09.08.26362490 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (616) Allergy and Immunology (898) Anesthesia (329) Cardiovascular Medicine (4788) Dentistry and Oral Medicine (477) Dermatology (412) Emergency Medicine (647) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1621) Epidemiology (15891) Forensic Medicine (32) Gastroenterology (1200) Genetic and Genomic Medicine (7013) Geriatric Medicine (730) Health Economics (1062) Health Informatics (5018) Health Policy (1430) Health Systems and Quality Improvement (1751) Hematology (583) HIV/AIDS (1340) Infectious Diseases (except HIV/AIDS) (16267) Intensive Care and Critical Care Medicine (1166) Medical Education (667) Medical Ethics (153) Nephrology (722) Neurology (7231) Nursing (366) Nutrition (1076) Obstetrics and Gynecology (1235) Occupational and Environmental Health (1002) Oncology (3589) Ophthalmology (1045) Orthopedics (396) Otolaryngology (449) Pain Medicine (466) Palliative Medicine (139) Pathology (705) Pediatrics (1787) Pharmacology and Therapeutics (734) Primary Care Research (762) Psychiatry and Clinical Psychology (5858) Public and Global Health (9731) Radiology and Imaging (2404) Rehabilitation Medicine and Physical Therapy (1442) Respiratory Medicine (1246) Rheumatology (637) Sexual and Reproductive Health (769) Sports Medicine (577) Surgery (774) Toxicology (107) Transplantation (303) Urology (289)
## Related Clinical Research

- [Semaglutide plus menopause hormone therapy linked to greater weight loss in midlife women](https://medichelpline.com/clinical-feed/medical-news-today-0-ozempic-plus-hormone-therapy-may-help-boost-weight-loss-at-menopause.md)
- [ADHD and dementia risk: new study links ADHD to later-life cognitive impairment](https://medichelpline.com/clinical-feed/medical-news-today-1-is-adhd-a-risk-factor-for-dementia-new-research-suggests-it-might-be.md)
- [Multimorbidity with tuberculosis in Kampala: prevalence, care gaps and impact on outcomes](https://medichelpline.com/clinical-feed/medrxiv-1-multimorbidity-in-tuberculosis-and-its-impact-on-health-and-treatment-outcomes.md)
- [Delayed ART initiation and low nadir CD4 count linked to worse mood in adults with chronic HIV](https://medichelpline.com/clinical-feed/medrxiv-19-delay-in-antiretroviral-therapy-initiation-is-associated-with-worse-mood.md)
- [Understanding Parasitic Identification in Delusional Parasitosis](https://medichelpline.com/clinical-feed/plos-one-21-bridging-perception-and-reality-parasitic-identification-in-delusional.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.